Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Elligo Health Research on the deal while Holland & Knight represented Morgan Stanley Expansion Capital and Ally Bridge Group. Elligo Health Research announced its...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised G Squared Ascend I on the deal. Latham & Watkins represented Transfix. G Squared Ascend I (NYSE: GSQD), a special purpose acquisition company...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Forge Global on the deal. Forge Global announced its definitive merger agreement with Motive Capital Corp (NYSE: MOTV.U) sponsored by affiliates of Motive Partners....
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised TrueMotion on the deal. TrueMotion announced its acquisition by Cambridge Mobile Telematics. The transaction, which closed on June 16, unites the two leading...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Chiasma, Inc. on the deal. Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM:...
You must be a Standard 1 Year member to access this content.
